23rd  January, 2017

           Vol. VI; Issue:04


A Weekly e-Newsletter for News update on Competition Law and Policy




News Updates from India


News Updates from Other Jurisdictions


   Competition Commission slaps Rs206 crore fines on seven cement companies.

Read More


   Competition Commission of India clears MakeMyTrip-ibibo merger.

 Read More

   CCI approves Aspen Global - Glaxo smith Kline deal.

                                                                    Read More

   General Motors India SAIC deals get Competition Commissions Nod.

Read More

   SPNs $385MN buyout of Ten Sports cleared by Indian Competition Commission.
Read More





 Competition Commission probing pricey school uniforms.

                                                  Read More

 CCP imposes penalties on dairy drink producers.

                                             Read More

 ChemChina seeks US antitrust approval for Syngenta deal.

Read More

 2-tier cigarette tax against antitrust law.

Read More 

 Walgreens said to face antitrust concerns over Rite Aid fix.

Read More 

Scholarly Articles



  Competition, Inalienability, and the Economic Analysis of Patent Law.

                                                                                                                                         Read More 



Whats next in the Competition Policy & Law Course? Course by CIRC in association with NLUD



  Results for Certificate and Diploma Course Exams for module 1-4 and 5-8 will be announced soon.

  Presentation for module 6 is sent to the participants.


​ Online Certificate & Professional Diploma in Public Procurement powered by World Bank Certificate Course is free! Read More


Your feedback/comments/suggestions are welcome at:

CUTS Institute for Regulation & Competition (CIRC)

D-72, First Floor, HauzKhas, New Delhi- 110 016

Tel: 011-26863022/23, 41621232



 Disclaimer: The material/ information contained in this weekly newsletter do not constitute/ substitute professional/ institutional advice. This compilation of news and views is solely for educational/ academic purposes, without any commercial intent. CIRC assumes no responsibility for any errors, which despite all precautions, may be